Katholieke Universiteit te Leuven (KU Leuven)

Doctoral Researcher (pre-)clinical Research on Prostate Cancer

 
Published
WorkplaceLeuven, Flemish Region, Belgium
Category
Position

Description

DOCTORAL RESEARCHER (PRE-)CLINICAL RESEARCH ON PROSTATE CANCER

We are looking for a talented and highly motivated doctoral researcher to further develop our (pre-) clinical research program on prostate cancer.
The PhD position is embedded in the Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer (hypo-FLAME) 2.0 project, funded by Kom Op Tegen Kanker (KOTK; Stand Up Against Cancer). The project aims to investigate the feasibility and safety of a reduction in the overall treatment time of radiotherapy for prostate cancer patients, making use of hypofractionated stereotactic body radiotherapy with focal boosting. Furthermore, the clinical research part of this PhD project will be accompanied by a translational research part in which immune-monitoring of extreme hypofractionated treatment schedules in combination with focal boosting will be performed.
The PhD project will be realized within the FLAME consortium consisting of the radiation oncology departments of The Netherlands Cancer Institute Amsterdam (NKI-AvL), Radboud University Medical Center Nijmegen (RadboudUMC) and the University Hospitals Leuven (UZL). A close collaboration and multicentric contacts are therefore inherent within this project.

The host lab: The Laboratory of Experimental Radiotherapy of the Department of Oncology at KU Leuven has profiled itself as a translational research lab with strong ties to the clinical Department of Radiation Oncology of UZ Leuven. This intense collaboration allows to perform real "from bench to bedside, and back" research with the overall aim to maximize tumour control and reduce radiation-treatment related side effects. Some of the key research topics are the modulation of molecular pathways that determine tumour radiation response in order to induce radiosensitization, the identification of novel biomarkers and the conduction of clinical trials. The host institution: KU Leuven is Belgium’s leading university and is continuously in the top 10 of the worlds’ most innovative universities. Core facilities with highest quality of service include the genomics core, the molecular small animal imaging centre (MoSAIC), MutaMouse (genome engineering service), cell imaging core (CIC), animal facility, microscopy core, electron microscopy, FACS core, mass spectrometry center, phosphoproteomics analysies, and many more.

The host lab: The Laboratory of Experimental Radiotherapy of the Department of Oncology at KU Leuven has profiled itself as a translational research lab with strong ties to the clinical Department of Radiation Oncology of UZ Leuven. This intense collaboration allows to perform real "from bench to bedside, and back" research with the overall aim to maximize tumour control and reduce radiation-treatment related side effects. Some of the key research topics are the modulation of molecular pathways that determine tumour radiation response in order to induce radiosensitization, the identification of novel biomarkers and the conduction of clinical trials. The host institution: KU Leuven is Belgium’s leading university and is continuously in the top 10 of the worlds’ most innovative universities. Core facilities with highest quality of service include the genomics core, the molecular small animal imaging centre (MoSAIC), MutaMouse (genome engineering service), cell imaging core (CIC), animal facility, microscopy core, electron microscopy, FACS core, mass spectrometry center, phosphoproteomics analysies, and many more.

  • A master’s degree within the field of medical sciences;
  • Experience in radiation oncology or urology is an advantage (can be part of a residency);
  • Curiosity and ambition to learn new skills and techniques;
  • Good communication skills relevant for working in an interdisciplinary research group;
  • Fluency in both oral and written English;
  • International applicants are expected to learn Dutch.

KU Leuven seeks to foster an environment where all talents can flourish, regardless of gender, age, cultural background, nationality or impairments. If you have any questions relating to accessibility or support, please contact us at diversiteit.HR [at] kuleuven[.]be.

Web

In your application, please refer to myScience.be and reference JobID 3126.

Related News



This site uses cookies and analysis tools to improve the usability of the site. More information. |